You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1139 Virotherapy with CodaLytic™, a codon-modified influenza virus, induces an anti-tumor immune microenvironment across preclinical models with different immune contextures

Alerts

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1139 Virotherapy with CodaLytic™, a codon-modified influenza virus, induces an anti-tumor immune microenvironment across preclinical models with different immune contextures
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address